Sexual attraction existed in different cultures is controversial. Pheromones have been determined to play a role in sexual attraction between people. They influence gonadal hormone secretion, for example, follicle maturation in the ovaries in females and testosterone and sperm production in males. Research conducted by Donald G. Dutton and Arthur P. Aron in the 1970s aimed to find the relation between sexual attraction and high anxiety conditions. In doing so, 85 male participants were contacted by an attractive female interviewer at either a fear-arousing suspension bridge or a normal bridge. Conclusively, it was shown that the male participants who were asked to
Transgender hormone therapy (male-to-female) Transgender hormone therapy (male-to-female) Transgender hormone therapy of the male-to-female (MTF) type, also known as feminizing hormone therapy, is hormone therapy and sex reassignment therapy to change the secondary sexual characteristics of transgender people from masculine (or androgynous) to feminine. It is one of two types of transgender hormone therapy (the other being female-to-male) and is predominantly used to treat transgender women and other transfeminine individuals. Some intersex people also take this form of therapy, according to their personal needs and preferences. The purpose of the therapy is to cause the development of the secondary sex characteristics of the desired